lucentis

Lucentis FDA Approved to Treat Diabetic Macular Edema

News / By / 1 minute of reading

The FDA has approved Lucentis (Ranibizumab) to treat diabetic macular edema as a monthly injection, making it the first drug approved to treat the condition. The 0.3mg one time dosage that has been approved is estimated to cost roughly $1,170.  The newly approved drug has been shown to be quite efficacious in improving vision in …

Lucentis FDA Approved to Treat Diabetic Macular Edema Read More »

Lucentis Backed by FDA Pannel for Extended Approval

Clinical Optometry, News / By / 1 minute of reading

U.S regulatory advisors have backed Lucentis for approval in treatment of diabetic macular edema. The FDA panel recommended the agency to approve a 0.5mg and 0.3mg dose of Lucentis in the treatment of DME. The FDA should decide sometime in August on the approval of the drug for as a treatment option. If approved, Lucentis …

Lucentis Backed by FDA Pannel for Extended Approval Read More »

Scroll to Top